General MedicationsSINGLE-USEStandard
BOTOX
OnabotulinumtoxinA
Standard Dose
200 UNITS/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview BOTOX is listed in Drugs@FDA under application 103000 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OnabotulinumtoxinA Form and strength VIAL; SINGLE-USE - 200 UNITS/VIAL Sponsor ALLERGAN Submission history Latest submission status date: 2024-10-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview BOTOX is listed in Drugs@FDA under application 103000 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient OnabotulinumtoxinA Form and strength VIAL; SINGLE-USE - 200 UNITS/VIAL Sponsor ALLERGAN Submission history Latest submission status date: 2024-10-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.